• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION MAGNESIUM; PHOTOMETRIC METHOD, MAGNESIUM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION MAGNESIUM; PHOTOMETRIC METHOD, MAGNESIUM Back to Search Results
Catalog Number 03P68-24
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/04/2023
Type of Reportable Event Malfunction
Event or Problem Description
The customer observed a falsely elevated magnesium result generated on the architect c4000 processing module for one sample.The following data was provided (customer provided reference range: 1.6 to 2.6 mg/dl): 04jul2023 sid078500166a initial result = 6.5 mg/dl, repeat = 1.93 mg/dl no impact to patient management was reported.
 
Additional Manufacturer Narrative
Completed information for section a1 patient identifier: (b)(4) an evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event or Problem Description
The customer observed a falsely elevated magnesium result generated on the architect c4000 processing module for one sample.The following data was provided (customer provided reference range: 1.6 to 2.6 mg/dl): 04jul2023 (b)(6) initial result = 6.5 mg/dl, repeat = 1.93 mg/dl.No impact to patient management was reported.
 
Additional Manufacturer Narrative
The complaint investigation for falsely elevated magnesium results included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, and field data review.Return testing was not completed as returns were not available.Trending review did not identify any trends for the issue for the product.Device history record review did not identify any non-conformances or deviations with lot 46427ud00 and the complaint issue.The overall performance of magnesium was reviewed using field data from customers worldwide.The patient data was analyzed and shows the patient median is within the established limits.Therefore, no unusual reagent lot performance was identified for lot 46427ud00.Labeling was reviewed and found to be adequate.Based on our investigation, no systemic issue or deficiency with the magnesium reagent for lot 46427ud00 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MAGNESIUM
Common Device Name
PHOTOMETRIC METHOD, MAGNESIUM
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI  N39E932
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI   N39E932
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key17418948
Report Number3005094123-2023-00200
Device Sequence Number13005754
Product Code JGJ
UDI-Device Identifier00380740169855
UDI-Public00380740169855
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 09/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/29/2023
Device Catalogue Number03P68-24
Device Lot Number46427UD00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 07/10/2023
Supplement Date Received by Manufacturer09/11/2023
Initial Report FDA Received Date07/28/2023
Supplement Report FDA Received Date09/11/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured01/10/2023
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARC C4000 INTGR, 02P24-40, C402070; ARC C4000 INTGR, 02P24-40, C402070
Patient SexUnknown
-
-